Xencor | Lånekapital



Loan Capital Endring Dato
AbbVie USD 60.34B 1.83B 2024-12
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amgen USD 54.01B 2.54B 2025-03
Arrowhead Research USD 407.79M 14.61M 2024-12
AstraZeneca USD 27.89B 154M 2025-03
Biogen USD 4.55B 1.4M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Cytokinetics USD 645.6M 1.1M 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
J&J USD 38.36B 7.7B 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 33.48B 978M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.64B 234M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Xencor USD 115.16M 104.99M 2024-12



Xencor Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.